Company registration number 04365324 (England and Wales)
HEART CONSULTANTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 5 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
HEART CONSULTANTS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
HEART CONSULTANTS LIMITED
BALANCE SHEET
AS AT
5 APRIL 2025
05 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
9,833
12,199
Cash at bank and in hand
148,746
184,582
158,579
196,781
Creditors: amounts falling due within one year
4
(34,304)
(46,062)
Net current assets
124,275
150,719
Capital and reserves
Called up share capital
5
100
100
Profit and loss reserves
124,175
150,619
Total equity
124,275
150,719

For the financial year ended 5 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
Dr M J van der Watt
Director
Company registration number 04365324 (England and Wales)
HEART CONSULTANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 5 APRIL 2025
- 2 -
1
Accounting policies
Company information

Heart Consultants Limited is a private company limited by shares incorporated in England and Wales. The registered office is 100 Barbirolli Square, Manchester, United Kingdom, M2 3BD.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts recognised by the company in respect of goods and services supplied, exclusive of Value Added Tax and trade discounts. Turnover principally consists of fees for the provision of cardiology consultancy services, which are recognised at the point of which the services are provided.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

HEART CONSULTANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 5 APRIL 2025
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
9,833
12,199
HEART CONSULTANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 5 APRIL 2025
- 4 -
4
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
30,543
41,537
Other creditors
3,761
4,525
34,304
46,062
5
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
100
100
100
100
2025-04-052024-04-06falsefalsefalse23 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityDr M J van der WattMrs MLF van der WattMrs MLF van der Watt043653242024-04-062025-04-05043653242025-04-05043653242024-04-0504365324core:WithinOneYear2025-04-0504365324core:WithinOneYear2024-04-0504365324core:CurrentFinancialInstruments2025-04-0504365324core:CurrentFinancialInstruments2024-04-0504365324core:ShareCapital2025-04-0504365324core:ShareCapital2024-04-0504365324core:RetainedEarningsAccumulatedLosses2025-04-0504365324core:RetainedEarningsAccumulatedLosses2024-04-0504365324core:ShareCapitalOrdinaryShareClass12025-04-0504365324core:ShareCapitalOrdinaryShareClass12024-04-0504365324bus:Director12024-04-062025-04-05043653242023-04-062024-04-0504365324bus:OrdinaryShareClass12024-04-062025-04-0504365324bus:OrdinaryShareClass12025-04-0504365324bus:OrdinaryShareClass12024-04-0504365324bus:PrivateLimitedCompanyLtd2024-04-062025-04-0504365324bus:SmallCompaniesRegimeForAccounts2024-04-062025-04-0504365324bus:FRS1022024-04-062025-04-0504365324bus:AuditExemptWithAccountantsReport2024-04-062025-04-0504365324bus:Director22024-04-062025-04-0504365324bus:CompanySecretary12024-04-062025-04-0504365324bus:FullAccounts2024-04-062025-04-05xbrli:purexbrli:sharesiso4217:GBP